4.7 Article

Petri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activation

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-017-00651-5

关键词

-

资金

  1. British Skin Foundation
  2. Wellcome Trust Sir Henry Dale Fellowship
  3. Biotechnology and Biological Sciences Research Council [BB/J004235]
  4. BBSRC [RA1344]
  5. Biotechnology and Biological Sciences Research Council [BBS/E/D/10002071, BB/I001107/1, BBS/E/D/20211552, BBS/E/D/05191131] Funding Source: researchfish
  6. BBSRC [BBS/E/D/10002071, BB/I001107/1, BBS/E/D/20211552, BBS/E/D/05191131] Funding Source: UKRI

向作者/读者索取更多资源

Langerhans cells (LCs) are able to orchestrate adaptive immune responses in the skin by interpreting the microenvironmental context in which they encounter foreign substances, but the regulatory basis for this has not been established. Utilising systems immunology approaches combining in silico modelling of a reconstructed gene regulatory network (GRN) with in vitro validation of the predictions, we sought to determine the mechanisms of regulation of immune responses in human primary LCs. The key role of Interferon regulatory factors (IRFs) as controllers of the human Langerhans cell response to epidermal cytokines was revealed by whole transcriptome analysis. Applying Boolean logic we assembled a Petri net-based model of the IRF-GRN which provides molecular pathway predictions for the induction of different transcriptional programmes in LCs. In silico simulations performed after model parameterisation with transcription factor expression values predicted that human LC activation of antigen-specific CD8T cells would be differentially regulated by epidermal cytokine induction of specific IRF-controlled pathways. This was confirmed by in vitro measurement of IFN-gamma production by activated T cells. As a proof of concept, this approach shows that stochastic modelling of a specific immune networks renders transcriptome data valuable for the prediction of functional outcomes of immune responses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Dermatology

British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021

R. A. Sabroe, F. Lawlor, C. E. H. Grattan, M. R. Ardern-Jones, A. Bewley, L. Campbell, C. Flohr, T. A. Leslie, A. M. Marsland, G. Ogg, W. A. C. Sewell, M. Hashme, L. S. Exton, M. F. Mohd Mustapa, M. C. Ezejimofor

BRITISH JOURNAL OF DERMATOLOGY (2022)

Letter Dermatology

A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the UK 2013-2018

M. Kwiatkowska, S. Ahmed, M. R. Ardern-Jones, L. A. Bhatti, T. O. Bleiker, A. Gavin, S. Hussain, D. W. Huws, L. Irvine, S. M. Langan, G. W. M. Millington, H. Mitchell, R. Murphy, L. Paley, C. M. Proby, C. S. Thomson, R. Thomas, C. Turner, S. Vernon, Z. C. Venables

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce

Angela L. Bosma, Annelie H. Musters, Manja Bloem, Louise A. A. Gerbens, Maritza A. Middelkamp-Hup, Eva Haufe, Jochen Schmitt, Sebastien Barbarot, Julien Seneschal, Delphine Staumont-Salle, Emma K. Johansson, Maria Bradley, Laura B. von Kobyletzki, Ida Vittrup, Iben Frier Ruge, Jacob P. Thyssen, Christian Vestergaard, Marina de Vega, Ignacio Garcia-Doval, Andrea Chiricozzi, Luca Stingeni, Piergiacomo Calzavara-Pinton, Michael R. Ardern-Jones, Nick J. Reynolds, Carsten Flohr, Phyllis Spuls

Summary: The TREAT Registry Taskforce is a collaborative network collecting real-world data on atopic eczema patients. This study provides an overview of the eight established TREAT registries and examines the overlap and pooling ability of their datasets. The results show that pooled analyses can be performed on multiple important domain items, enabling future comparative analyses.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Review Allergy

Utility and Safety of Skin Tests in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Systematic Review

Ying Xin Teo, Peter Simon Friedmann, Marta Ewa Polak, Michael Roger Ardern-Jones

Summary: Skin tests, particularly patch tests and intradermal tests, have been reported as valuable tools in assessing drug causality in DRESS. However, the heterogeneity in methodology, results analysis, and reporting of cohorts make it impossible to determine the sensitivity and specificity of the published literature. International collaboration is needed to harmonize the methodology and reporting measures in larger hypersensitivity testing studies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Letter Dermatology

Successful dose reduction of dupilumab in atopic dermatitis

Michael R. Ardern-Jones, Emily E. Buchanan, Samba Njungu, Daniel O'Driscoll

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Dermatology

Skin programming of inflammatory responses to Staphylococcus aureus is compartmentalized according to epidermal keratinocyte differentiation status

Kalum Clayton, Daniel J. Holbrook, Andres Vallejo, Gemma Porter, Sofia Sirvent, James Davies, Jenny Pople, Fei Ling Lim, Myron Christodoulides, Marta E. Polak, Michael R. Ardern-Jones

Summary: This study explores the interaction between keratinocyte proliferation and differentiation status and the skin microbiome. It is found that Staphylococcus epidermidis is significantly associated with the human epidermis and can induce epidermal inflammation and antimicrobial responses. Furthermore, it activates the expression of inflammatory mediators in other epidermal immune cell populations. Understanding the mechanisms of bacterial sensing-triggered inflammatory responses will further our understanding of microbiome dysbiosis and inflammatory skin diseases.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Multidisciplinary Sciences

A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort

Michael R. Ardern-Jones, Hang T. T. Phan, Florina Borca, Matt Stammers, James Batchelor, Isabel C. Reading, Sophie V. Fletcher, Trevor Smith, Andrew S. Duncombe

Summary: Blood markers can predict mortality in COVID-19 patients, and early dexamethasone treatment can reduce mortality in high-risk patients but not in low-risk patients. The risk-benefit of dexamethasone should be carefully assessed in COVID-19 cases, and alternative approaches should be considered for low-risk patients.

PLOS ONE (2023)

Article Dermatology

Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial

Carsten Flohr, Michael J. Cork, Michael R. Ardern-Jones, Lawrence F. Eichenfield, Sebastien Barbarot, Claire Feeney, Ricardo Rojo, Irina Lazariciu, John Nesnas

Summary: The study evaluated the response to treatment with continuous/reduced-dose abrocitinib or withdrawal and reintroduction after flare in adolescents and adults with atopic dermatitis. It found that abrocitinib was effective in preventing flare in both age groups, with no significant difference in response between adolescents and adults.

JOURNAL OF DERMATOLOGICAL TREATMENT (2023)

Review Chemistry, Analytical

Electromagnetic Sensing Techniques for Monitoring Atopic Dermatitis-Current Practices and Possible Advancements: A Review

Alexandar Todorov, Russel Torah, Michael R. Ardern-Jones, Steve P. Beeby

Summary: Atopic dermatitis (AD) is a prevalent skin disorder, particularly in children and adolescents, with current assessment methods relying on visual examination by clinicians. However, this approach is subjective and limited. Digital sensing technologies offer a potential solution for accurate and empirical evaluation of AD, allowing for global access. This review focuses on current medical practices, alternative digital evaluation methods, and potential future technologies to develop an AD monitoring device.

SENSORS (2023)

Article Multidisciplinary Sciences

Impaired expression of metallothioneins contributes to allergen-induced inflammation in patients with atopic dermatitis

Sofia Sirvent, Andres F. Vallejo, Emma Corden, Ying Teo, James Davies, Kalum Clayton, Eleanor G. Seaby, Chester Lai, Sarah Ennis, Rfeef Alyami, Gemma Douilhet, Lareb S. N. Dean, Matthew Loxham, Sarah Horswill, Eugene Healy, Graham Roberts, Nigel J. Hall, Peter S. Friedmann, Harinder Singh, Clare L. Bennett, Michael R. Ardern-Jones, Marta E. Polak

Summary: Regulation of cutaneous immunity is compromised in inflammatory skin disease, such as atopic dermatitis. A study investigating molecular crosstalk in atopic dermatitis patients exposed to house dust mite has revealed a distinct dichotomy in patient responsiveness and identified potential therapeutic targets for modulation of metallothionein expression. The presence of hub structures where Langerhans cells and T cells co-localize suggests their role in the reactivity to house dust mite.

NATURE COMMUNICATIONS (2023)

Review Dermatology

Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise

Margo Waters, Allison Dobry, Stephanie T. Le, Kanade Shinkai, Thomas M. Beachkofsky, Mark D. P. Davis, Arturo R. Dominguez, Daniela Kroshinsky, Alina Markova, Robert G. Micheletti, Arash Mostaghimi, Helena B. Pasieka, Misha Rosenbach, Lucia Seminario-Vidal, John Trinidad, Joerg Albrecht, Emily M. Altman, Ryan Arakaki, Michael Arden-Jones, Alina G. Bridges, Adela R. Cardones, Angad A. Chadha, Jennifer K. Chen, Steven T. Chen, Kyle Cheng, Steven Daveluy, Katherine L. DeNiro, Joanna Harp, Jesse J. Keller, Brett King, Abraham M. Korman, Eve J. Lowenstein, Erin Luxenberg, Jennifer Brescoll Mancuso, Melissa M. Mauskar, Philip Milam, Kiran Motaparthi, Caroline A. Nelson, Cuong V. Nguyen, Fnu Nutan, Alex G. Ortega-Loayza, Tejesh Patel, Sahand Rahnama-Moghadam, Sergey Rekhtman, Nathan W. Rojek, Mansi Sarihan, Sheila Shaigany, Timmie R. Sharma, Sabrina M. Shearer, Bridget E. Shields, Lindsay C. Strowd, Danielle M. Tartar, Cristina Thomas, Karolyn A. Wanat, Andrew C. Walls, Lisa C. Zaba, Carolyn M. Ziemer, Emanual Maverakis, Benjamin H. Kaffenberger

Summary: This article discusses the importance of developing a skin-directed scoring system for EN, including consistent terminology and morphologic traits, as well as identifying the most affected sites. Through a Delphi consensus exercise, it was determined that there is a need for a skin-directed scoring system for EN.

JAMA DERMATOLOGY (2023)

Meeting Abstract Dermatology

Efficacy and safety of abrocitinib in biologic-exposed versus biologic-naive patients with moderate-to-severe atopic dermatitis

M. Gooderham, B. Strober, M. Ardern-Jones, E. Guttman-Yassky, M. Levenberg, G. Chan, P. Biswas, M. Watkins

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Meeting Abstract Dermatology

Efficacy of abrocitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis who had an inadequate response or intolerance to nonsteroidal immunosuppressants: results from JADE DARE

Michael Ardern-Jones, Mahreen Ameen, Marjolein de Bruin-Weller, Eric Simpson, Wing Sin Chiu, Fan Zhang, Gary Chan, Christopher Koulias, Stephan Weidinger

BRITISH JOURNAL OF DERMATOLOGY (2022)

Meeting Abstract Dermatology

Clinical benefit of baricitinib treatment for moderate-to-severe atopic dermatitis in combination with topical corticosteroids: a post hoc analysis of the BREEZE-AD7 and BREEZE-AD4 phase III trials

Mahreen Ameen, Michael Ardern-Jones, Hamish Hunter, Susanne Grond, Fan Emily Yang, Yun-Fei Chen, Robert McKenzie, Alan Irvine

BRITISH JOURNAL OF DERMATOLOGY (2022)

暂无数据